Production (Stage)
AVITA Medical, Inc.
AVHHL
$1.42
-$0.01-0.70%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 71.66M | 64.25M | 60.04M | 54.14M | 50.70M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 71.66M | 64.25M | 60.04M | 54.14M | 50.70M |
Cost of Revenue | 10.41M | 9.09M | 8.61M | 7.53M | 7.63M |
Gross Profit | 61.25M | 55.16M | 51.43M | 46.61M | 43.07M |
SG&A Expenses | 90.99M | 91.37M | 88.10M | 80.03M | 72.39M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -59.00K | -271.00K | -801.00K |
Total Operating Expenses | 122.85M | 120.82M | 118.93M | 108.53M | 100.64M |
Operating Income | -51.19M | -56.57M | -58.89M | -54.39M | -49.94M |
Income Before Tax | -57.01M | -61.79M | -57.27M | -49.74M | -44.75M |
Income Tax Expenses | 32.00K | 54.00K | 47.00K | 86.00K | 66.00K |
Earnings from Continuing Operations | -57.05 | -61.85 | -57.32 | -49.83 | -44.82 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -57.05M | -61.85M | -57.32M | -49.83M | -44.82M |
EBIT | -51.19M | -56.57M | -58.89M | -54.39M | -49.94M |
EBITDA | -49.75M | -55.45M | -57.98M | -53.63M | -49.24M |
EPS Basic | -2.19 | -2.39 | -2.23 | -1.95 | -1.76 |
Normalized Basic EPS | -1.35 | -1.47 | -1.53 | -1.38 | -1.26 |
EPS Diluted | -2.19 | -2.39 | -2.23 | -1.95 | -1.76 |
Normalized Diluted EPS | -1.35 | -1.47 | -1.53 | -1.38 | -1.26 |
Average Basic Shares Outstanding | 104.14M | 103.53M | 102.86M | 102.28M | 101.76M |
Average Diluted Shares Outstanding | 104.14M | 103.53M | 102.86M | 102.28M | 101.76M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |